360 related articles for article (PubMed ID: 33766750)
41. Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway.
Li Z; Qian J; Li J; Zhu C
Exp Ther Med; 2019 Jul; 18(1):435-442. PubMed ID: 31281438
[TBL] [Abstract][Full Text] [Related]
42. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
Abu N; Hon KW; Jeyaraman S; Jamal R
Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
[TBL] [Abstract][Full Text] [Related]
43. Exosome-mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer.
Wang X; Pei X; Guo G; Qian X; Dou D; Zhang Z; Xu X; Duan X
J Cell Physiol; 2020 Oct; 235(10):6896-6904. PubMed ID: 31994191
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNAs regulate drug resistance in cancer.
Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
[TBL] [Abstract][Full Text] [Related]
45. Lnc-ing epigenetic mechanisms with autophagy and cancer drug resistance.
Nandi S; Mondal A; Ghosh A; Mukherjee S; Das C
Adv Cancer Res; 2023; 160():133-203. PubMed ID: 37704287
[TBL] [Abstract][Full Text] [Related]
46. LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells.
Xiong M; Wu M; Dan Peng ; Huang W; Chen Z; Ke H; Chen Z; Song W; Zhao Y; Xiang AP; Zhong X
Cell Death Dis; 2021 Jan; 12(1):24. PubMed ID: 33414433
[TBL] [Abstract][Full Text] [Related]
47. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
48. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
[TBL] [Abstract][Full Text] [Related]
49. Advances in long non-coding RNA regulating drug resistance of cancer.
Ying Z; Wenjing S; Jing B; Songbin F; Kexian D
Gene; 2023 Dec; 887():147726. PubMed ID: 37625566
[TBL] [Abstract][Full Text] [Related]
50. Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer.
Zhang HB; Hu Y; Deng JL; Fang GY; Zeng Y
Front Pharmacol; 2023; 14():1243934. PubMed ID: 37781691
[TBL] [Abstract][Full Text] [Related]
51. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
Wu H; Gu J; Zhou D; Cheng W; Wang Y; Wang Q; Wang X
J Cell Mol Med; 2020 Aug; 24(15):8589-8602. PubMed ID: 32652877
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
[TBL] [Abstract][Full Text] [Related]
53. Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization.
Mallappa S; Neeli PK; Karnewar S; Kotamraju S
Mol Carcinog; 2019 Jul; 58(7):1118-1133. PubMed ID: 30834613
[TBL] [Abstract][Full Text] [Related]
54. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
Shang C; Guo Y; Zhang J; Huang B
Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
[TBL] [Abstract][Full Text] [Related]
55. Long Non-coding RNA H19 Recruits NFYB to Activate MBTD1 and Regulate Doxorubicin Resistance in Lymphoma Cells.
Feng L; Yan Q; Xu X
Mol Biotechnol; 2023 Jun; 65(6):997-1009. PubMed ID: 36434485
[TBL] [Abstract][Full Text] [Related]
56. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
Singh D; Khan MA; Siddique HR
Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
[TBL] [Abstract][Full Text] [Related]
57. Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer.
Yang G; Shen T; Yi X; Zhang Z; Tang C; Wang L; Zhou Y; Zhou W
J Cell Mol Med; 2018 Apr; 22(4):2062-2070. PubMed ID: 29392884
[TBL] [Abstract][Full Text] [Related]
58. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L
Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832
[TBL] [Abstract][Full Text] [Related]
59. Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance.
Alemi F; Poornajaf Y; Hosseini F; Vahedian V; Gharekhani M; Shoorei H; Taheri M
Mol Biol Rep; 2024 Feb; 51(1):308. PubMed ID: 38366290
[TBL] [Abstract][Full Text] [Related]
60. A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer.
Liu L; Li X
Curr Cancer Drug Targets; 2020; 20(5):325-334. PubMed ID: 32186268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
